Inhibition of Mycobacterial Growth In Vitro following Primary but Not Secondary Vaccination with Mycobacterium bovis BCG

Despite the widespread use of the Mycobacterium bovis BCG vaccine, there are more than 9 million new cases of tuberculosis (TB) every year, and there is an urgent need for better TB vaccines. TB vaccine candidates are selected for evaluation based in part on the detection of an antigen-specific gamm...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Fletcher, Helen A., Tanner, Rachel, Wallis, Robert S., Meyer, Joel, Manjaly, Zita-Rose, Harris, Stephanie, Satti, Iman, Silver, Richard F., Hoft, Dan, Kampmann, Beate, Walker, K. Barry, Dockrell, Hazel M., Fruth, Uli, Barker, Lew, Brennan, Michael J., McShane, Helen
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2013
Soggetti:
Vaccines
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3837779/
https://ncbi.nlm.nih.gov/pubmed/23986316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00427-13
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi